ArticlePloS one2018

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.

Mi Jeong Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.